04/16/2025 3:18 PM | AlloVir (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/11/2025 4:04 PM | AlloVir (Issuer) PATEL SAMIR CHANDRAKANT (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/11/2025 4:08 PM | Jovan-Embiricos Morana (Reporting) AlloVir (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/11/2025 4:20 PM | AKKARAJU SRINIVAS (Reporting) AlloVir (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/11/2025 4:27 PM | Hagen Brett R (Reporting) AlloVir (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/11/2025 4:03 PM | Ferrara Napoleone (Reporting) AlloVir (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/11/2025 3:41 PM | Hallal David (Reporting) AlloVir (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2025 7:21 AM | AlloVir (Issuer) PATTERSON LEONE D (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/04/2025 7:12 AM | AlloVir (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/27/2025 6:19 PM | Hagen Brett R (Reporting) AlloVir (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/26/2025 4:06 PM | AKKARAJU SRINIVAS (Reporting) AlloVir (Issuer)
| Form 3/A | |
Get the Latest News and Ratings for ALVR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for AlloVir and its competitors with MarketBeat's FREE daily newsletter.
|
03/25/2025 6:38 PM | AlloVir (Issuer) Samsara BioCapital GP, LLC (Reporting) Samsara BioCapital, L.P. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
03/25/2025 6:40 PM | AlloVir (Subject) Samsara BioCapital, L.P. (Filed by)
| Form SCHEDULE 13D | |
03/20/2025 3:32 PM | GILEAD SCIENCES, INC. (Filed by) AlloVir (Subject)
| Form SCHEDULE 13G/A | |
03/18/2025 4:44 PM | AlloVir (Issuer) PATEL SAMIR CHANDRAKANT (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2025 4:45 PM | Ferrara Napoleone (Reporting) AlloVir (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2025 4:37 PM | ADAMIS ANTHONY P (Reporting) AlloVir (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2025 4:40 PM | AKKARAJU SRINIVAS (Reporting) AlloVir (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2025 4:41 PM | AlloVir (Issuer) Oxtoby Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2025 4:43 PM | Feinsod Matthew (Reporting) AlloVir (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2025 4:25 PM | Dybbs Michael (Reporting) AlloVir (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
03/18/2025 4:27 PM | Ferrara Napoleone (Reporting) AlloVir (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
03/18/2025 4:30 PM | AKKARAJU SRINIVAS (Reporting) AlloVir (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
03/18/2025 4:14 PM | ADAMIS ANTHONY P (Reporting) AlloVir (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
03/18/2025 4:17 PM | Feinsod Matthew (Reporting) AlloVir (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
03/18/2025 4:20 PM | AlloVir (Issuer) Oxtoby Andrew (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
03/18/2025 4:21 PM | AlloVir (Issuer) PATEL SAMIR CHANDRAKANT (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
03/18/2025 4:04 PM | AlloVir (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/12/2025 3:18 PM | AlloVir (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/07/2025 6:30 AM | AlloVir (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/24/2025 10:51 AM | AlloVir (Subject) Hagen Brett R (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/24/2025 10:55 AM | AlloVir (Subject) Miller Edward (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/24/2025 10:56 AM | AlloVir (Subject) Sinha Vikas (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025 12:17 PM | AlloVir (Subject) EcoR1 Capital, LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/10/2025 11:15 PM | AlloVir (Filer)
| Form EFFECT | |
02/10/2025 3:19 PM | AlloVir (Filer)
| Form 424B3 | |
01/24/2025 1:51 PM | AlloVir (Subject) Hagen Brett R (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2025 1:55 PM | AlloVir (Subject) Miller Edward (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2025 2:03 PM | AlloVir (Subject) Sinha Vikas (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/15/2025 3:39 PM | AlloVir (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/15/2025 3:41 PM | AlloVir (Subject)
| Form 425 | |
The Man I Turn to In Times Like This (Ad) A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.”
Tilson just released a new prediction that runs counter to what mainstream finance is telling you. Market chaos? Hear Tilson’s take now |
01/13/2025 3:15 PM | AlloVir (Issuer) Sinha Vikas (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/13/2025 3:15 PM | AlloVir (Issuer) Hagen Brett R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/13/2025 3:15 PM | AlloVir (Issuer) Miller Edward (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2025 7:00 PM | AlloVir (Subject) Hagen Brett R (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2025 7:00 PM | AlloVir (Subject) Sinha Vikas (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2025 7:00 PM | AlloVir (Subject) Miller Edward (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2025 6:44 AM | AlloVir (Subject)
| Form 425 | |
01/10/2025 6:42 AM | AlloVir (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/20/2024 3:21 PM | AlloVir (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/20/2024 3:23 PM | AlloVir (Subject)
| Form 425 | |
12/11/2024 4:07 PM | AlloVir (Issuer) Miller Edward (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/09/2024 5:37 AM | AlloVir (Filer)
| Form S-4 Registration statement under Securities Act of 1933 | |
12/06/2024 8:50 PM | AlloVir (Subject)
| Form 425 | |
12/06/2024 6:23 AM | AlloVir (Filer)
| Form DEF 14A | |
11/20/2024 3:15 PM | AlloVir (Issuer) Brainard Diana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/20/2024 3:15 PM | AlloVir (Issuer) Miller Edward (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/20/2024 3:15 PM | AlloVir (Issuer) Sinha Vikas (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/20/2024 3:15 PM | AlloVir (Issuer) Hagen Brett R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/19/2024 7:00 PM | AlloVir (Subject) Hagen Brett R (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/19/2024 7:00 PM | AlloVir (Subject) Brainard Diana (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/19/2024 7:00 PM | AlloVir (Subject) Miller Edward (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/19/2024 7:00 PM | AlloVir (Subject) Sinha Vikas (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2024 3:05 PM | AlloVir (Subject)
| Form 425 | |
11/08/2024 3:06 PM | AlloVir (Subject)
| Form 425 | |
11/08/2024 3:09 PM | AlloVir (Subject)
| Form 425 | |
11/08/2024 3:10 PM | AlloVir (Subject)
| Form 425 | |
11/08/2024 7:26 AM | AlloVir (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/08/2024 7:33 AM | AlloVir (Subject)
| Form 425 | |
11/05/2024 7:00 PM | AlloVir (Subject) Sinha Vikas (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/05/2024 7:00 PM | AlloVir (Subject) Hagen Brett R (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/05/2024 7:00 PM | AlloVir (Subject) Miller Edward (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/05/2024 7:00 PM | AlloVir (Subject) Brainard Diana (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024 3:15 PM | AlloVir (Issuer) Miller Edward (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/23/2024 3:15 PM | AlloVir (Issuer) Hagen Brett R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/23/2024 3:15 PM | AlloVir (Issuer) Sinha Vikas (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/23/2024 3:15 PM | AlloVir (Issuer) Brainard Diana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/22/2024 7:00 PM | AlloVir (Subject) Sinha Vikas (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/22/2024 7:00 PM | AlloVir (Subject) Miller Edward (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/22/2024 7:00 PM | AlloVir (Subject) Hagen Brett R (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/21/2024 7:00 PM | AlloVir (Subject) Miller Edward (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/21/2024 7:00 PM | AlloVir (Subject) Brainard Diana (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/21/2024 7:00 PM | AlloVir (Subject) Sinha Vikas (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/21/2024 7:00 PM | AlloVir (Subject) Hagen Brett R (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/04/2024 3:15 PM | AlloVir (Issuer) Hagen Brett R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2024 3:15 PM | AlloVir (Issuer) Brainard Diana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2024 3:15 PM | AlloVir (Issuer) Miller Edward (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2024 3:15 PM | AlloVir (Issuer) Sinha Vikas (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 7:00 PM | AlloVir (Subject) Miller Edward (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024 7:00 PM | AlloVir (Subject) Sinha Vikas (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024 7:00 PM | AlloVir (Subject) Hagen Brett R (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
What President Trump’s Executive Order 14154 means for your money (Ad) Nearly $3 trillion disappeared from the stock market on Thursday morning.
According to Whitney Tilson - a former hedge fund manager who predicted the dotcom crash, the housing crisis, and the 2022 tech stock bloodbath - a little-known executive order from the President's first day in office could spark a paradigm-shift that will likely catch millions of Americans off guard. But because of the massive changes impacting U.S. stocks, Tilson has agreed to publish his latest fi |
10/03/2024 7:00 PM | AlloVir (Subject) Brainard Diana (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2024 3:15 PM | AlloVir (Issuer) Brainard Diana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2024 10:14 AM | AlloVir (Subject) Brainard Diana (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024 3:15 PM | AlloVir (Issuer) Brainard Diana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2024 3:15 PM | AlloVir (Issuer) Sinha Vikas (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2024 3:15 PM | AlloVir (Issuer) Hagen Brett R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2024 3:15 PM | AlloVir (Issuer) Miller Edward (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2024 7:00 PM | AlloVir (Subject) Sinha Vikas (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024 7:00 PM | AlloVir (Subject) Hagen Brett R (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |